DG NIMR Calls For Antiretroviral Therapy Study
- Written by Oluwafemi Olowookere
The Director General, Nigerian Institute of Medical Research (NIMR), Prof. Babatunde Salako has called for the implementation of the study of antiretroviral therapy in Nigeria for the betterment of HIV/AIDS patients.
The DG NIMR made this call on, during the presentation of a report conducted between September 2013 to September 2016 with theme, HIV drug resistance: Implication for optimizing Antiretroviral Therapy in Abuja.
Prof. Salako noted that the NIMR has the responsibly to conduct research on diseases of public health concern. He said that the institute would ensure that the results of such research are properly disseminated to the relevant stakeholders in the health sector and Nigerian in general.
He informed that there was a new method of treating HIV and AIDS patients in Nigeria. He added the method was achieved as result of collaboration between the University of Jos, University College Ibadan, Harvard T. H Chan School of public health, Boston –USA, APIN public health Initiative and GLOBOMICS LLC, Atlanta – USA as Consulting partner.
Earlier in his remark, the Director General of National Agency for the Control of AIDS (NACA), Dr. Sanni Aliyu, said that the finding of the study was very important in improving the treatment of HIV patients in the Country. He assured that the report would be disseminated to the relevant stakeholders in the country.